MARTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 12.646
EU - Europa 6.579
AS - Asia 6.545
SA - Sud America 1.106
AF - Africa 122
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.030
Nazione #
US - Stati Uniti d'America 12.288
IT - Italia 2.778
SG - Singapore 2.755
CN - Cina 1.760
DE - Germania 1.056
BR - Brasile 954
HK - Hong Kong 638
UA - Ucraina 553
FI - Finlandia 495
GB - Regno Unito 450
VN - Vietnam 367
TR - Turchia 354
NL - Olanda 229
CA - Canada 199
RU - Federazione Russa 193
SE - Svezia 148
ID - Indonesia 138
FR - Francia 132
MX - Messico 128
PL - Polonia 124
IN - India 122
RO - Romania 113
JP - Giappone 107
ZA - Sudafrica 69
ES - Italia 63
AR - Argentina 62
BD - Bangladesh 52
LT - Lituania 48
BE - Belgio 38
IQ - Iraq 34
AT - Austria 33
PK - Pakistan 32
CZ - Repubblica Ceca 30
AU - Australia 26
CH - Svizzera 25
AE - Emirati Arabi Uniti 21
EC - Ecuador 20
UZ - Uzbekistan 20
IR - Iran 19
MA - Marocco 17
CL - Cile 16
PE - Perù 16
CO - Colombia 15
IL - Israele 13
KR - Corea 13
SA - Arabia Saudita 13
PT - Portogallo 10
MY - Malesia 9
PH - Filippine 9
TH - Thailandia 9
TW - Taiwan 9
HU - Ungheria 8
PY - Paraguay 8
AZ - Azerbaigian 7
DZ - Algeria 7
NP - Nepal 7
UY - Uruguay 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
EG - Egitto 6
IE - Irlanda 6
KE - Kenya 6
KG - Kirghizistan 6
VE - Venezuela 6
AL - Albania 5
GR - Grecia 5
JO - Giordania 5
KZ - Kazakistan 5
PA - Panama 5
TN - Tunisia 5
BG - Bulgaria 4
CR - Costa Rica 4
HN - Honduras 4
JM - Giamaica 4
OM - Oman 4
RS - Serbia 4
BA - Bosnia-Erzegovina 3
EE - Estonia 3
LB - Libano 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
EU - Europa 2
GT - Guatemala 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SN - Senegal 2
AD - Andorra 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
Totale 27.009
Città #
Singapore 1.634
Ashburn 1.522
Fairfield 1.078
Woodbridge 979
Santa Clara 694
Beijing 689
Hong Kong 624
Houston 614
Chandler 604
Munich 568
Dallas 542
Jacksonville 540
Seattle 430
Ann Arbor 393
Wilmington 389
Cambridge 378
Ferrara 314
Milan 300
Helsinki 261
Los Angeles 254
New York 232
Izmir 194
Princeton 158
Rome 146
Nanjing 142
Shanghai 138
Boardman 129
Ho Chi Minh City 115
San Diego 107
Jakarta 102
Warsaw 101
Hanoi 98
Turku 94
Tokyo 86
London 80
São Paulo 80
Bologna 79
Mexico City 77
The Dalles 71
Hefei 70
Redwood City 68
Chicago 66
Brooklyn 65
Buffalo 57
Denver 56
Orem 54
Falkenstein 52
Poplar 48
Toronto 48
Johannesburg 47
Chennai 45
Montreal 45
Florence 44
Bremen 43
Hebei 42
Stockholm 42
Shenyang 40
Atlanta 39
Moscow 38
Tianjin 38
Boston 37
San Francisco 37
Falls Church 36
Brussels 33
Rio de Janeiro 33
Amsterdam 32
Frankfurt am Main 32
San Jose 32
Nuremberg 31
Ankara 30
Naples 29
Nanchang 27
Norwalk 27
Washington 27
Mountain View 26
Ottawa 26
Cagliari 25
Changsha 25
Jiaxing 25
Curitiba 24
Council Bluffs 23
Querétaro 23
Phoenix 22
San Mateo 22
Jyväskylä 21
Manchester 21
Turin 21
Auburn Hills 19
Brno 19
Leawood 18
Padova 18
Tashkent 18
Verona 18
Augusta 17
North Bergen 17
Salt Lake City 17
Biên Hòa 16
Porto Alegre 16
Belo Horizonte 15
Rancho Palos Verdes 15
Totale 17.053
Nome #
Effetti acuti di JWH-018 e dei suoi sostituti alogenati sulle funzioni sensori-motorie del topo 847
Dall’America all’Asia: Salvia divinorum e Mitragyna speciosa 805
Autoerotic death: un unusual case of lethal asphyxiophilia associated with autogynephilia 642
1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice 371
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 346
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 344
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 335
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence 303
Forensic DNA phenotyping: prediction of human externally visible traits in missing person identification 293
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 278
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: JWH-018 273
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 254
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 244
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 240
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 237
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 219
Un distillato Bohémienne tuttora famoso: l’assenzio 215
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 211
The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure 208
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 203
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels 202
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 199
Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications 196
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease 192
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 190
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 190
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 190
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity 190
Loss of cortical GABA terminals in Unverricht–Lundborg disease 189
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels 185
Striatal Dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors 182
JWH-018 impairs sensorimotor functions in mice 182
Changes of glutamatergic control of striatal acetylcholine release in experimental parkinsonism 179
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 179
Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington’s disease 179
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 176
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 176
Antagonisti dei recettori NOP e loro usi terapeutici 175
Application of 13 loci STR multiplex for cannabis sativa genotyping 174
Choose the cause of death: a complex suicide 174
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography–tandem mass spectrometry investigation 173
Application of 13 loci STR multiplex for the cannabis sativa genotyping 173
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 172
Droghe da stupro: il GHB ed i suoi analoghi 171
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors 171
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway 170
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands 170
Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice 169
Kindled seizure-evoked somatostatin release in the hippocampus: inhibition by MK-801 166
Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation 166
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 162
Cutaneous miRNAs expression in human hanging injuries 162
NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms 161
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 161
DNA recovery from immunochromatographic membranes 160
Novel Synthetic Opioids: The Pathologist's Point of View 159
Forensic DNA Phenotyping (FDP): A Prediction of Human Externally Visible Traits in Missing Person Identification 159
Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats 158
Ayahuasca: il vino dell'anima 158
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 158
Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice 157
Differential role of striatal and nigral D1receptors in the expression of L-DOPA induced dyskinesia and its neurochemical correlates 156
The synthetic cathinones MDPHP and MDPV: Comparison of the acute effects in mice, in silico ADMET profiles and clinical reports 152
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 152
Agonisti dei recettori NOP per il trattamento delle discinesie da levodopa; 149
Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro 149
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat 143
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model 143
Mrna profiling in casework analyses 143
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release 142
Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish 142
JWH-018 and its N-pentyl-halogenated derivates impair sensory motor functions in mice. 139
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: An electrophysiological study 138
Reply to "MDPV-induced aggression in humans not established" 138
Accidental Autoerotic Death: An Unusual Case of Lethal Asphyxiophilia Associated With Autogynephilia 137
In vitro and in vivo pharmaco-toxicological characterization of 1-cyclohexyl-x-methoxybenzene derivatives in mice: comparison with tramadol and PCP 136
In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45 134
Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat 133
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 132
Nociceptin/orphanin FQ receptors modulate locomotion and motor cortex excitability in adult Rats 132
Synthetic cannabinoid JWH-018 impairs object recognition memory in mice: behavioral and electrophysiological evidence 132
Novel therapeutic strategies for treatment of motor abnormalities in Parkinson’s disease: focus on opioid receptors 130
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum 129
Trichocereuspachanoi: quando la globalizzazione minaccia la tradizione. 128
Regulation of miRNAs as new tool for cutaneous vitality lesions demonstration in ligature marks in deaths by hanging 128
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 128
L-DOPA-induced modulation of GABA and glutamate release in the substantia nigra pars reticulata and globus pallidus in a rat model of dyskinesia 126
Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs 124
Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats 124
Nociceptin/orphanin FQ receptor antagonists as a novel therapeutic approach to Parkinson’s disease: interaction with levodopa 122
null 121
Comparison of N-methyl-2-pyrrolidone (NMP) and the “date rape” drug GHB: behavioral toxicology in the mouse model 121
Low-normal doses of methiopropamine induce aggressive behaviour in mice 119
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin 118
Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe 118
Studio degli effetti acuti e cronici e delle proprietà d’abuso del cannabinoide sintetico JWH-018: un approccio multidisciplinare 117
Nociceptin/orphanin FQ modulates neurotransmitter release in the substantia nigra: Biochemical and behavioural outcome 117
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice 116
Metabolic profile of the synthetic drug 4,4′-dimethylaminorex in urine by LC–MS-based techniques: selection of the most suitable markers of its intake 116
L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors 116
Totale 19.163
Categoria #
all - tutte 122.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.343
Totale 123.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.347 0 0 0 0 0 176 96 283 84 294 271 143
2021/20221.501 79 181 124 52 87 66 99 69 45 105 144 450
2022/20231.602 179 145 81 150 232 177 104 133 226 28 93 54
2023/20241.386 96 105 65 48 123 204 76 107 56 82 77 347
2024/20256.429 206 174 532 318 550 749 487 475 945 551 805 637
2025/20268.534 1.620 652 1.554 1.763 2.309 636 0 0 0 0 0 0
Totale 27.398